Dimerix Limited
Trending Articles
Related Content
Manufacturing
Dimerix announces tablet manufacture and human pharmacokinetic study timeline
Dimerix announces manufacturing has been scheduled for later this month to produce the extended release tablet of propagermanium, which will be used in the Company’s DMX-200 human pharmacokinetic study and Phase 2b trial in Chronic Kidney Disease